Showing results (91-100 of 375) with videos related to
Sort By:
Pageof 38
Journal of Nuclear Medicine Technology|August 15, 2015
Diagnosis of Dual Malignancy by 18F-FDG PET/CT in the Setting of Paraneoplastic Cerebellar DegenerationPradeep Thapa, Sandip BasuCancer Biotherapy & Radiopharmaceuticals|April 20, 2016
Correlating and Combining Genomic and Proteomic Assessment with In Vivo Molecular Functional Imaging: Will This Be the Future Roadmap for Personalized Cancer Management?Bhakti Basu, Sandip BasuJournal of Nuclear Medicine Technology|April 20, 2022
Metachronous Adenocarcinoma of the Lung in the Setting of Metastatic Gastric Neuroendocrine Tumor: Value of Elucidating Discordance on Dual-Tracer PET/CT with Ki-67 IndexSarvesh Loharkar, Sandip BasuThe Quarterly Journal of Nuclear Medicine and Molecular Imaging : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR), [And] Section of the Society Of|July 5, 2019
Leveraging the power of non-radium radionuclide treatments in bone metastasesPradeep Thapa, Sandip BasuNuclear Medicine Review. Central & Eastern Europe|June 26, 2009
Revolutionary impact of PET and PET-CT on the day-to-day practice of medicine and its great potential for improving future health careSandip Basu, Abass AlaviWorld Journal of Nuclear Medicine|May 30, 2017
Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATE for Metastatic Neuroendocrine Tumor Occurring in Association with Multiple Endocrine Neoplasia Type 1 and Cushing's SyndromeChinna Naik, Sandip BasuIndian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|April 13, 2018
Discordant Primary Resistance to Imatinib Mesylate in the Same Individual and Splenic Involvement in Recurring Gastric Gastrointestinal Stromal Tumors: Assessment by Fluorodeoxyglucose-Positron Emission Tomography/Computed TomographyPreeti Fargose, Sandip BasuWorld Journal of Nuclear Medicine|April 14, 2021
Grade 3 metastatic neuroendocrine neoplasms of two unusual primary sites with contrasting differentiation characteristics: Dual tracer positron emission tomography and computed tomography imaging (<sup>18</sup>F-fluorodeoxyglucose and <sup>68</sup>Ga-DOTATATE) correlates and their treatment implicationsSarvesh Loharkar, Sandip BasuJournal of Nuclear Medicine Technology|March 1, 2020
Occurrence of the Redifferentiation-Akin Phenomenon on <sup>68</sup>Ga-DOTATATE PET/CT After CAPTEM Chemotherapy in Metastatic Neuroendocrine Tumors with Intermediate MIB1 Index: What Could Be the Molecular Explanation?Priyanka Sharma, Sandip BasuClinical Nuclear Medicine|March 15, 2005
Unsuspected metastatic male breast nodule from synovial sarcoma detected by FDG PETNarendra Nair, Sandip BasuPageof 38